Interfering with apoptosis: Ca2+-binding protein ALG-2 and Alzheimer's disease gene ALG-3

Science

Volumn 271, Issue 5248, 1996, Pages 521-525

  Vito, Pasquale ^a   Lacaná, Emanuela ^a   D'Adamio, Luciano ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STAPHYLOCOCCUS PHAGE 3A;

CALCIUM BINDING PROTEIN; FAS ANTIGEN; GLUCOCORTICOID; T LYMPHOCYTE RECEPTOR;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CELL DEATH; GENE; GENETIC ANALYSIS; HYBRIDOMA; PRIORITY JOURNAL;

ALKALOIDS; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD95; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CALCIUM; CALCIUM-BINDING PROTEINS; CELL LINE; CLONING, MOLECULAR; DACTINOMYCIN; DEXAMETHASONE; DNA, COMPLEMENTARY; FAS LIGAND PROTEIN; HYBRIDOMAS; INTERLEUKIN-2; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; PRESENILIN-2; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; STAUROSPORINE; T-LYMPHOCYTES; TRANSFECTION; UP-REGULATION;

EID: 0029671219     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.271.5248.521     Document Type: Article

References (58)

1. J. F R. Kerr, A. H Wyllie, A. R. Currie, Br. J. Cancer 26, 239 (1972).
2. C. B. Thompson, Science 267, 1456 (1995).
3. J. D. Ashwell, R. E. Cunningham, P. D. Noguchi, D. Hernandez, J. Exp. Med. 165, 173 (1987); Y Shi et al., J. Immunol. 144, 3326 (1990).
4. J. D. Ashwell, R. E. Cunningham, P. D. Noguchi, D. Hernandez, J. Exp. Med. 165, 173 (1987); Y Shi et al., J. Immunol. 144, 3326 (1990).
5. +] mRNA was prepared from 3DO cells stimulated with the monoclonal antibody to CDSε 2C11 (Pharmingen), which was immobilized on tissue culture plates (1 μg/ml), for 0 to 5 hours. Therefore, both constitutive transcripts and mRNAs regulated either positively or negatively by TCR stimulation were represented. After reverse transcription with random and oligo(dT) primers, the cDNA was cloned into the vector pLTP, which was designed to obtain eukaryotic expression of cloned cDNAs from cytomegalovirus (CMV) enhancer-promoter sequences and to replicate episomally in mouse cells (P. Vito and L. D'Adamio, unpublished data). The pLTP vector was derived from plasmid pcDNA3 (Invitrogen) as follows: The neomycin resistance gene was excised and a fragment of polyoma virus, encoding the targe T antigen and the viral origin of replication, was cloned into a Bsp Hl site The cDNA library was transiently transfected into 3DO cells with DEAE dextran (450 mg/ml). Eighteen hours later, the transfected cells were stimulated with 2C11 immobilized on tissue culture plates to trigger PCD. After 12 hours, the living cells were recovered and lysed in 0.6% SDS and 10 mM EDTA to isolate circular non-integrated plasmids. The rescued vectors were transformed into XL2-Blue MRF' ultracompetent cells (Stratagene) to obtain sub libraries. This procedure was repeated four times. Two groups have also described systems based on the selection of apoptotic genes by antisense RNA-mediated PCD inhibition [T. G. Gabig, P. L. Mantel, R. Rosli, C. D. Cream, J. Biol. Chem. 269, 29515 (1994); L P Deiss, E. Feinstein, H. Berissi, O. Cohen, A. Kimchi, Genes Dev. 9, 15 (1995)].
6. +] mRNA was prepared from 3DO cells stimulated with the monoclonal antibody to CDSε 2C11 (Pharmingen), which was immobilized on tissue culture plates (1 μg/ml), for 0 to 5 hours. Therefore, both constitutive transcripts and mRNAs regulated either positively or negatively by TCR stimulation were represented. After reverse transcription with random and oligo(dT) primers, the cDNA was cloned into the vector pLTP, which was designed to obtain eukaryotic expression of cloned cDNAs from cytomegalovirus (CMV) enhancer-promoter sequences and to replicate episomally in mouse cells (P. Vito and L. D'Adamio, unpublished data). The pLTP vector was derived from plasmid pcDNA3 (Invitrogen) as follows: The neomycin resistance gene was excised and a fragment of polyoma virus, encoding the targe T antigen and the viral origin of replication, was cloned into a Bsp Hl site The cDNA library was transiently transfected into 3DO cells with DEAE dextran (450 mg/ml). Eighteen hours later, the transfected cells were stimulated with 2C11 immobilized on tissue culture plates to trigger PCD. After 12 hours, the living cells were recovered and lysed in 0.6% SDS and 10 mM EDTA to isolate circular non-integrated plasmids. The rescued vectors were transformed into XL2-Blue MRF' ultracompetent cells (Stratagene) to obtain sub libraries. This procedure was repeated four times. Two groups have also described systems based on the selection of apoptotic genes by antisense RNA-mediated PCD inhibition [T. G. Gabig, P. L. Mantel, R. Rosli, C. D. Cream, J. Biol. Chem. 269, 29515 (1994); L P Deiss, E. Feinstein, H. Berissi, O. Cohen, A. Kimchi, Genes Dev. 9, 15 (1995)].
7. P Vito, E Lacaná, L. D'Adamio, unpublished data.
8. H. Kageyama, M. Shimizu, K. Tokunaga, T. Hiwasa, S. Sakiyama, Biochim Biophys. Acta 1008, 255 (1989).
9. R. H. Kretsinger and G E. Nockolds, J. Biol Chem. 248, 3313 (1973); R. M Tufty and R. H Kretsinger, Science 187, 167 (1975).
10. R. H. Kretsinger and G E. Nockolds, J. Biol Chem. 248, 3313 (1973); R. M Tufty and R. H Kretsinger, Science 187, 167 (1975).
11. E. Levy-Lahad et al., Science 269, 970 (1995); E. Levy-Lahad et al., ibid., p. 973. The same gene has also been identified and called E5-1 by E. I. Rogaev et al. [Nature 376, 775 (1995)].
12. E. Levy-Lahad et al., Science 269, 970 (1995); E. Levy-Lahad et al., ibid., p. 973. The same gene has also been identified and called E5-1 by E. I. Rogaev et al. [Nature 376, 775 (1995)].
13. E. Levy-Lahad et al., Science 269, 970 (1995); E. Levy-Lahad et al., ibid., p. 973. The same gene has also been identified and called E5-1 by E. I. Rogaev et al. [Nature 376, 775 (1995)].
14. The A25 and B75 inserts were ∼1200 and 350 bp long and identified transcripts of ∼4.5 and 2.7 kb in 3DO cells. Sequence analysis revealed no homology with known genes (5).
15. E. Lacaná, P. Vito, L D'Adamio, unpublished data.
16. J. Dhein, H. Walczack, C. Baumler, K.-M. Debatin, P H. Krammer, Nature 373, 438 (1995); T Brunner et al., ibid , p. 441; S.-T Ju et al , ibid., p. 444.
17. J. Dhein, H. Walczack, C. Baumler, K.-M. Debatin, P H. Krammer, Nature 373, 438 (1995); T Brunner et al., ibid , p. 441; S.-T Ju et al , ibid., p. 444.
18. J. Dhein, H. Walczack, C. Baumler, K.-M. Debatin, P H. Krammer, Nature 373, 438 (1995); T Brunner et al., ibid , p. 441; S.-T Ju et al , ibid., p. 444.
19. A. H. Wyllie, ibid. 284, 555 (1980)
20. C. M. Zacharchuk et al., J. Immunol 145, 4037 (1990); Y. Yang, M. Mercep, C. F. Ware, J. D. Ashwell, J. Exp. Med. 181, 1673 (1995).
21. C. M. Zacharchuk et al., J. Immunol 145, 4037 (1990); Y. Yang, M. Mercep, C. F. Ware, J. D. Ashwell, J. Exp. Med. 181, 1673 (1995).
22. M G. Cifone et al., J. Exp Med. 177, 1547 (1993), E. Gulbins et al., Immunity 2, 341 (1995).
23. M G. Cifone et al., J. Exp Med. 177, 1547 (1993), E. Gulbins et al., Immunity 2, 341 (1995).
24. M. D. Jacobson, J. F. Burne, M. C. Raff, EMBO J. 13, 1899 (1994)
25. H. Kizaki, T. Tadakuma, C. Odaka, J Muramatsu, Y. Ishimura, J. Immunol 143, 1790 (1989)
26. D. R. Newish and L. A. Burgoyne, Biochem Biophys. Res Comm 52, 504 (1973); J. N Vanderbilt, K S. Bloom, J. N. Anderson, J Biol. Chem. 257, 13009 (1982); J. J. Cohen and R C. Duke, J. Immunol. 132, 38 (1984), A. H Wyllie, R. H. Morris, A. L. Smith, D. Dunlop, J. Pathol. 142, 67 (1984).
27. D. R. Newish and L. A. Burgoyne, Biochem Biophys. Res Comm 52, 504 (1973); J. N Vanderbilt, K S. Bloom, J. N. Anderson, J Biol. Chem. 257, 13009 (1982); J. J. Cohen and R C. Duke, J. Immunol. 132, 38 (1984), A. H Wyllie, R. H. Morris, A. L. Smith, D. Dunlop, J. Pathol. 142, 67 (1984).
28. D. R. Newish and L. A. Burgoyne, Biochem Biophys. Res Comm 52, 504 (1973); J. N Vanderbilt, K S. Bloom, J. N. Anderson, J Biol. Chem. 257, 13009 (1982); J. J. Cohen and R C. Duke, J. Immunol. 132, 38 (1984), A. H Wyllie, R. H. Morris, A. L. Smith, D. Dunlop, J. Pathol. 142, 67 (1984).
29. D. R. Newish and L. A. Burgoyne, Biochem Biophys. Res Comm 52, 504 (1973); J. N Vanderbilt, K S. Bloom, J. N. Anderson, J Biol. Chem. 257, 13009 (1982); J. J. Cohen and R C. Duke, J. Immunol. 132, 38 (1984), A. H Wyllie, R. H. Morris, A. L. Smith, D. Dunlop, J. Pathol. 142, 67 (1984).
30. D. J McConkey, P. Hartzell, J. F. Amador-Perez, S Orrenius, M. Jondal, J. Immunol. 143, 1801 (1989).
31. D. J. McConkey et al., Arch. Biochem Biophys. 269, 365 (1989).
32. F Vignaux et al , J Exp Med 181, 781 (1995); Y Oshimi and S. Miyazaki, J Immunol 154, 599 (1995).
33. F Vignaux et al , J Exp Med 181, 781 (1995); Y Oshimi and S. Miyazaki, J Immunol 154, 599 (1995).
34. D J. McConkey, P. Hartzell, S K Duddy, Håkansson, S. Orrenius, Science 242, 256 (1988).
35. A. Sann, D. H. Adams, P. A. Henkart, J. Exp. Med 178, 1693 (1993); M K T Squier, A. C. K Miller, A. M. Malkinson, J J Cohen, J. Cell Physiol. 159, 229 (1994); A. Sann, H. Nakajiama, P. A Henkart, J. Immunol 154, 5806 (1995).
36. A. Sann, D. H. Adams, P. A. Henkart, J. Exp. Med 178, 1693 (1993); M K T Squier, A. C. K Miller, A. M. Malkinson, J J Cohen, J. Cell Physiol. 159, 229 (1994); A. Sann, H. Nakajiama, P. A Henkart, J. Immunol 154, 5806 (1995).
37. A. Sann, D. H. Adams, P. A. Henkart, J. Exp. Med 178, 1693 (1993); M K T Squier, A. C. K Miller, A. M. Malkinson, J J Cohen, J. Cell Physiol. 159, 229 (1994); A. Sann, H. Nakajiama, P. A Henkart, J. Immunol 154, 5806 (1995).
38. M. Enan, H. Hug, S. Nagata, Nature 375, 78 (1995); M. Los et al., ibid., p. 81
39. M. Enan, H. Hug, S. Nagata, Nature 375, 78 (1995); M. Los et al., ibid., p. 81
40. K. Kuida et al , Science 267, 2000 (1995).
41. D. T. Loo et al , Proc. Natl. Acad. Sci. U.SA 90, 7951 (1993); M. Gschwind and G Huber, J. Neurochem. 65, 292 (1995), F M. LaFerla, B. T Tinkle, C. J. Bieberich, C. C. Haudenschild, G. Jay, Nature Genet. 9, 21 (1995), J. H. Su, A. J. Anderson, B. J. Cummings, C W. Cotman, Neuroreport 5, 2529 (1994); H Lassmann et al., Acta Neuropathol 89, 35 (1995); C. W. Cotman and A. J. Anderson, Mol. Neurobiol. 10, 19 (1995).
42. D. T. Loo et al , Proc. Natl. Acad. Sci. U.SA 90, 7951 (1993); M. Gschwind and G Huber, J. Neurochem. 65, 292 (1995), F M. LaFerla, B. T Tinkle, C. J. Bieberich, C. C. Haudenschild, G. Jay, Nature Genet. 9, 21 (1995), J. H. Su, A. J. Anderson, B. J. Cummings, C W. Cotman, Neuroreport 5, 2529 (1994); H Lassmann et al., Acta Neuropathol 89, 35 (1995); C. W. Cotman and A. J. Anderson, Mol. Neurobiol. 10, 19 (1995).
43. D. T. Loo et al , Proc. Natl. Acad. Sci. U.SA 90, 7951 (1993); M. Gschwind and G Huber, J. Neurochem. 65, 292 (1995), F M. LaFerla, B. T Tinkle, C. J. Bieberich, C. C. Haudenschild, G. Jay, Nature Genet. 9, 21 (1995), J. H. Su, A. J. Anderson, B. J. Cummings, C W. Cotman, Neuroreport 5, 2529 (1994); H Lassmann et al., Acta Neuropathol 89, 35 (1995); C. W. Cotman and A. J. Anderson, Mol. Neurobiol. 10, 19 (1995).
44. D. T. Loo et al , Proc. Natl. Acad. Sci. U.SA 90, 7951 (1993); M. Gschwind and G Huber, J. Neurochem. 65, 292 (1995), F M. LaFerla, B. T Tinkle, C. J. Bieberich, C. C. Haudenschild, G. Jay, Nature Genet. 9, 21 (1995), J. H. Su, A. J. Anderson, B. J. Cummings, C W. Cotman, Neuroreport 5, 2529 (1994); H Lassmann et al., Acta Neuropathol 89, 35 (1995); C. W. Cotman and A. J. Anderson, Mol. Neurobiol. 10, 19 (1995).
45. D. T. Loo et al , Proc. Natl. Acad. Sci. U.SA 90, 7951 (1993); M. Gschwind and G Huber, J. Neurochem. 65, 292 (1995), F M. LaFerla, B. T Tinkle, C. J. Bieberich, C. C. Haudenschild, G. Jay, Nature Genet. 9, 21 (1995), J. H. Su, A. J. Anderson, B. J. Cummings, C W. Cotman, Neuroreport 5, 2529 (1994); H Lassmann et al., Acta Neuropathol 89, 35 (1995); C. W. Cotman and A. J. Anderson, Mol. Neurobiol. 10, 19 (1995).
46. D. T. Loo et al , Proc. Natl. Acad. Sci. U.SA 90, 7951 (1993); M. Gschwind and G Huber, J. Neurochem. 65, 292 (1995), F M. LaFerla, B. T Tinkle, C. J. Bieberich, C. C. Haudenschild, G. Jay, Nature Genet. 9, 21 (1995), J. H. Su, A. J. Anderson, B. J. Cummings, C W. Cotman, Neuroreport 5, 2529 (1994); H Lassmann et al., Acta Neuropathol 89, 35 (1995); C. W. Cotman and A. J. Anderson, Mol. Neurobiol. 10, 19 (1995).
47. 388) start codon (Fig. 2C) [S R. Hann, M. W King, D L. Bentley, C. W Anderson, R. N. Eisenman, Cell 52, 185 (1988); J Curran and D. Kolakofsky, EMBO J. 7 , 245 (1988); H Prats et al., Proc. Natl. Acad. Sci. U.S.A. 86, 1836 (1989), A.-C. Prats, S Vagner, H. Prats, F. Amalric, Mol. Cell. Biol. 12, 4796 (1992), S. Vagner et al., ibid 15, 35 (1995)]
48. 388) start codon (Fig. 2C) [S R. Hann, M. W King, D L. Bentley, C. W Anderson, R. N. Eisenman, Cell 52, 185 (1988); J Curran and D. Kolakofsky, EMBO J. 7 , 245 (1988); H Prats et al., Proc. Natl. Acad. Sci. U.S.A. 86, 1836 (1989), A.-C. Prats, S Vagner, H. Prats, F. Amalric, Mol. Cell. Biol. 12, 4796 (1992), S. Vagner et al., ibid 15, 35 (1995)]
49. 388) start codon (Fig. 2C) [S R. Hann, M. W King, D L. Bentley, C. W Anderson, R. N. Eisenman, Cell 52, 185 (1988); J Curran and D. Kolakofsky, EMBO J. 7 , 245 (1988); H Prats et al., Proc. Natl. Acad. Sci. U.S.A. 86, 1836 (1989), A.-C. Prats, S Vagner, H. Prats, F. Amalric, Mol. Cell. Biol. 12, 4796 (1992), S. Vagner et al., ibid 15, 35 (1995)]
50. 388) start codon (Fig. 2C) [S R. Hann, M. W King, D L. Bentley, C. W Anderson, R. N. Eisenman, Cell 52, 185 (1988); J Curran and D. Kolakofsky, EMBO J. 7 , 245 (1988); H Prats et al., Proc. Natl. Acad. Sci. U.S.A. 86, 1836 (1989), A.-C. Prats, S Vagner, H. Prats, F. Amalric, Mol. Cell. Biol. 12, 4796 (1992), S. Vagner et al., ibid 15, 35 (1995)]
51. 388) start codon (Fig. 2C) [S R. Hann, M. W King, D L. Bentley, C. W Anderson, R. N. Eisenman, Cell 52, 185 (1988); J Curran and D. Kolakofsky, EMBO J. 7 , 245 (1988); H Prats et al., Proc. Natl. Acad. Sci. U.S.A. 86, 1836 (1989), A.-C. Prats, S Vagner, H. Prats, F. Amalric, Mol. Cell. Biol. 12, 4796 (1992), S. Vagner et al., ibid 15, 35 (1995)]
52. Single-letter abbreviations for the amino acid residues are. A, Ala, C, Cys; D, Asp; E, Glu, F, Phe; G, Gly; H, His; I, lle; K, Lys, L, Leu; M, Met, N, Asn, P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp, and Y, Tyr.
53. I Nicoletti et al., J Immunol Methods 139, 271 (1991)
54. P Matzinger, ibid. 145, 185 (1991).
55. K. Maruyama, T Mikawa, S. Ebashi, J. Biochem. 95, 511 (1984).
56. G. Franzoso et al., Nature 359, 339 (1992), K Brown and U. Siebenlist, unpublished data.
57. G. Franzoso et al., Nature 359, 339 (1992), K Brown and U. Siebenlist, unpublished data.
58. We thank B Lawrence and K, Ganjei for technical assistance and R. H Schwanz, P. Matzinger, B. J. Fowlkes, F A. Flomerfelt, and M. Pagano for helpful discussion and comments on the manuscript. Special thanks to both K Brown and U Siebenlist for providing the GSTIkB recombinant protein